Zhejiang Hailide New Material (002206.SZ) plans to establish a wholly-owned subsidiary Zhejiang Hailide New Material Medical Technology Co., Ltd.

Zhejiang Hailide New Material (002206.SZ) announced that according to its strategic planning and future business development needs, the company plans to invest 50 million yuan of its own funds to establish a wholly-owned subsidiary, Zhejiang Hailide New Material Medical Technology Co., Ltd. (tentative name, subject to final approval by the industrial and commercial department). The establishment of the wholly-owned subsidiary, Zhejiang Hailide New Material Medical Technology Co., Ltd., is an important move to optimize the industrial layout and promote the implementation of the high-end new materials strategy, with far-reaching significance for achieving high-quality development and industrial transformation and upgrading. The company has long been focused on the research and development, production, and sales of industrial filament and tire cord fabrics, forming core competitive advantages and deep industrial accumulation in polymer material modification, fiber spinning technology, large-scale production, and manufacturing, and overall quality control. Medical materials and medical fiber materials are related to the company's existing core technologies, with similar processes. This business expansion is conducive to efficient conversion of core technologies and synergy in the industrial chain, further enhancing research and development capabilities and product added value.